Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Healthtrust
Covington
Medtronic
Argus Health
Federal Trade Commission
Chubb
Queensland Health

Generated: May 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 207865

« Back to Dashboard

NDA 207865 describes EMEND, which is a drug marketed by Merck, Msd Merck Co, and Merck And Co Inc, and is included in three NDAs. It is available from three suppliers. There are three patents protecting this drug and four Paragraph IV challenges. Additional details are available on the EMEND profile page.

The generic ingredient in EMEND is fosaprepitant dimeglumine. There are nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the fosaprepitant dimeglumine profile page.
Summary for 207865
Tradename:EMEND
Applicant:Msd Merck Co
Ingredient:aprepitant
Patents:2
Therapeutic Class:Antiemetics
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 207865
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
EMEND aprepitant FOR SUSPENSION;ORAL 207865 NDA Merck Sharp & Dohme Corp. 0006-3066 N 0006-3066-03

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:FOR SUSPENSION;ORALStrength125MG/KIT
Approval Date:Dec 17, 2015TE:RLD:Yes
Regulatory Exclusivity Expiration:Aug 28, 2018
Regulatory Exclusivity Use:NEW PATIENT POPULATION
Patent:➤ Sign UpPatent Expiration:Jul 1, 2018Product Flag?YSubstance Flag?YDelist Request?
Patented Use:PREVENTION OF NAUSEA AND VOMITING ASSOCIATED WITH CHEMOTHERAPY (CINV)
Patent:➤ Sign UpPatent Expiration:Sep 26, 2027Product Flag?YSubstance Flag?Delist Request?
Patented Use:PREVENTION OF NAUSEA AND VOMITING ASSOCIATED WITH CHEMOTHERAPY (CINV)

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Federal Trade Commission
Johnson and Johnson
Cantor Fitzgerald
Citi
Fuji
Fish and Richardson
Dow
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.